Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile". (journals.asm.org)

Authors: Fabrizio C … Tascini C Journal: Antimicrobial Agents and Chemotherapy Published: 2026-05-06 DOI: https://doi.org/10.1128/aac.00887-25